Cargando…
Effective dose of remimazolam co-administered with remifentanil to facilitate I-gel insertion without neuromuscular blocking agents: an up-and-down sequential allocation trial
BACKGROUND: Remimazolam is a new anesthetic drug developed and is an ultra-short-acting agent with rapid onset and offset. The pharmacology of this drug seems to be ideal for short surgeries eligible for I-gel insertion. Therefore, this study aimed to determine the optimal bolus dose of remimazolam...
Autores principales: | Oh, Juyeon, Park, Sung Yong, Lee, Ga Yun, Park, Ji Hyun, Joe, Han Bum |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018909/ https://www.ncbi.nlm.nih.gov/pubmed/36927413 http://dx.doi.org/10.1186/s12871-023-02041-z |
Ejemplares similares
-
Effective concentration of remifentanil for successful i-gel insertion during remimazolam induction
por: Choi, Jung Ju, et al.
Publicado: (2023) -
Comparison of remimazolam–remifentanil and propofol–remifentanil during laparoscopic cholecystectomy
por: Lee, Tae Young, et al.
Publicado: (2023) -
Remifentanil requirement for i-gel insertion is reduced in male patients with Parkinson’s disease undergoing deep brain stimulator implantation: an up-and-down sequential allocation trial
por: Meng, Wenjun, et al.
Publicado: (2022) -
The Median Effective Dose and Bispectral Index of Remimazolam Tosilate for Anesthesia Induction in Elderly Patients: An Up-and-Down Sequential Allocation Trial
por: Liu, Miao, et al.
Publicado: (2022) -
Determination of the 95% effective dose of remimazolam to achieve loss of consciousness during anesthesia induction in different age groups
por: Oh, Juyeon, et al.
Publicado: (2022)